These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35048967)

  • 21. Extracellular signal-regulated kinase pathway is differentially involved in beta-agonist-induced hypertrophy in slow and fast muscles.
    Shi H; Zeng C; Ricome A; Hannon KM; Grant AL; Gerrard DE
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1681-9. PubMed ID: 17151143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SGLT2 inhibitor canagliflozin suppresses lipid synthesis and interleukin-1 beta in ApoE deficient mice.
    Day EA; Ford RJ; Lu JH; Lu R; Lundenberg L; Desjardins EM; Green AE; Lally JSV; Schertzer JD; Steinberg GR
    Biochem J; 2020 Jun; 477(12):2347-2361. PubMed ID: 32510137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fish protein intake induces fast-muscle hypertrophy and reduces liver lipids and serum glucose levels in rats.
    Kawabata F; Mizushige T; Uozumi K; Hayamizu K; Han L; Tsuji T; Kishida T
    Biosci Biotechnol Biochem; 2015; 79(1):109-16. PubMed ID: 25198797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment.
    Derave W; Van Den Bosch L; Lemmens G; Eijnde BO; Robberecht W; Hespel P
    Neurobiol Dis; 2003 Aug; 13(3):264-72. PubMed ID: 12901841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term ursolic acid promotes skeletal muscle rejuvenation through enhancing of SIRT1 expression and satellite cells proliferation.
    Bakhtiari N; Hosseinkhani S; Soleimani M; Hemmati R; Noori-Zadeh A; Javan M; Tashakor A
    Biomed Pharmacother; 2016 Mar; 78():185-196. PubMed ID: 26898441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels.
    Suga T; Kikuchi O; Kobayashi M; Matsui S; Yokota-Hashimoto H; Wada E; Kohno D; Sasaki T; Takeuchi K; Kakizaki S; Yamada M; Kitamura T
    Mol Metab; 2019 Jan; 19():1-12. PubMed ID: 30416006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) Inhibition.
    Basu D; Huggins LA; Scerbo D; Obunike J; Mullick AE; Rothenberg PL; Di Prospero NA; Eckel RH; Goldberg IJ
    Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2207-2216. PubMed ID: 30354257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative Metabolomics, Enzymatic Activity, and Gene Expression Analysis Provide Insights into the Metabolic Profile Differences between the Slow-Twitch Muscle and Fast-Twitch Muscle of
    Wang H; Li B; Li A; An C; Liu S; Zhuang Z
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats.
    Londzin P; Brudnowska A; Kurkowska K; Wilk K; Olszewska K; Ziembiński Ł; Janas A; Cegieła U; Folwarczna J
    Biomed Pharmacother; 2022 Nov; 155():113679. PubMed ID: 36099792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice.
    Lynch GS; Cuffe SA; Plant DR; Gregorevic P
    Neuromuscul Disord; 2001 Apr; 11(3):260-8. PubMed ID: 11297941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium-glucose co-transporter-2 (SGLT-2) inhibition reduces glucose uptake to induce breast cancer cell growth arrest through AMPK/mTOR pathway.
    Zhou J; Zhu J; Yu SJ; Ma HL; Chen J; Ding XF; Chen G; Liang Y; Zhang Q
    Biomed Pharmacother; 2020 Dec; 132():110821. PubMed ID: 33068934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The sodium-glucose co-transporter-2 inhibitor ertugliflozin modifies the signature of cardiac substrate metabolism and reduces cardiac mTOR signalling, endoplasmic reticulum stress and apoptosis.
    Moellmann J; Mann PA; Kappel BA; Kahles F; Klinkhammer BM; Boor P; Kramann R; Ghesquiere B; Lebherz C; Marx N; Lehrke M
    Diabetes Obes Metab; 2022 Nov; 24(11):2263-2272. PubMed ID: 35801343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Model-Based Evaluation of Proximal Sodium Reabsorption Through SGLT2 in Health and Diabetes and the Effect of Inhibition With Canagliflozin.
    Brady JA; Hallow KM
    J Clin Pharmacol; 2018 Mar; 58(3):377-385. PubMed ID: 29144539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arginine promotes skeletal muscle fiber type transformation from fast-twitch to slow-twitch via Sirt1/AMPK pathway.
    Chen X; Guo Y; Jia G; Liu G; Zhao H; Huang Z
    J Nutr Biochem; 2018 Nov; 61():155-162. PubMed ID: 30236872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tofogliflozin Improves Insulin Resistance in Skeletal Muscle and Accelerates Lipolysis in Adipose Tissue in Male Mice.
    Obata A; Kubota N; Kubota T; Iwamoto M; Sato H; Sakurai Y; Takamoto I; Katsuyama H; Suzuki Y; Fukazawa M; Ikeda S; Iwayama K; Tokuyama K; Ueki K; Kadowaki T
    Endocrinology; 2016 Mar; 157(3):1029-42. PubMed ID: 26713783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH.
    Shiba K; Tsuchiya K; Komiya C; Miyachi Y; Mori K; Shimazu N; Yamaguchi S; Ogasawara N; Katoh M; Itoh M; Suganami T; Ogawa Y
    Sci Rep; 2018 Feb; 8(1):2362. PubMed ID: 29402900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac ischemia-reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity.
    Yoshii A; Nagoshi T; Kashiwagi Y; Kimura H; Tanaka Y; Oi Y; Ito K; Yoshino T; Tanaka TD; Yoshimura M
    Cardiovasc Diabetol; 2019 Jul; 18(1):85. PubMed ID: 31262297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATP consumption by sarcoplasmic reticulum Ca2+ pumps accounts for 50% of resting metabolic rate in mouse fast and slow twitch skeletal muscle.
    Norris SM; Bombardier E; Smith IC; Vigna C; Tupling AR
    Am J Physiol Cell Physiol; 2010 Mar; 298(3):C521-9. PubMed ID: 20018953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure.
    Nambu H; Takada S; Fukushima A; Matsumoto J; Kakutani N; Maekawa S; Shirakawa R; Nakano I; Furihata T; Katayama T; Yamanashi K; Obata Y; Saito A; Yokota T; Kinugawa S
    Eur J Pharmacol; 2020 Jan; 866():172810. PubMed ID: 31738936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma.
    Jojima T; Wakamatsu S; Kase M; Iijima T; Maejima Y; Shimomura K; Kogai T; Tomaru T; Usui I; Aso Y
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31652578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.